Global Live Attenuated Japanese Encephalitis Vaccine Supply, Demand and Key Producers, 2023-2029
The global Live Attenuated Japanese Encephalitis Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Epidemic Japanese encephalitis (hereinafter referred to as 'JE') is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report studies the global Live Attenuated Japanese Encephalitis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Japanese Encephalitis Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Japanese Encephalitis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Live Attenuated Japanese Encephalitis Vaccine total production and demand, 2018-2029, (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine total production value, 2018-2029, (USD Million)
Global Live Attenuated Japanese Encephalitis Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Live Attenuated Japanese Encephalitis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Japanese Encephalitis Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Live Attenuated Japanese Encephalitis Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech and Cheng Da Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Japanese Encephalitis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Live Attenuated Japanese Encephalitis Vaccine Market, By Region:
1. How big is the global Live Attenuated Japanese Encephalitis Vaccine market?
2. What is the demand of the global Live Attenuated Japanese Encephalitis Vaccine market?
3. What is the year over year growth of the global Live Attenuated Japanese Encephalitis Vaccine market?
4. What is the production and production value of the global Live Attenuated Japanese Encephalitis Vaccine market?
5. Who are the key producers in the global Live Attenuated Japanese Encephalitis Vaccine market?
6. What are the growth factors driving the market demand?
Epidemic Japanese encephalitis (hereinafter referred to as 'JE') is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report studies the global Live Attenuated Japanese Encephalitis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Japanese Encephalitis Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Japanese Encephalitis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Live Attenuated Japanese Encephalitis Vaccine total production and demand, 2018-2029, (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine total production value, 2018-2029, (USD Million)
Global Live Attenuated Japanese Encephalitis Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Live Attenuated Japanese Encephalitis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Japanese Encephalitis Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Live Attenuated Japanese Encephalitis Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech and Cheng Da Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Japanese Encephalitis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Live Attenuated Japanese Encephalitis Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 0.5ml
- 1ml
- 2.5ml
- Hospital
- Clinic
- Novartis
- Sanofi
- Chengdu Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Beijing Temple of Heaven Biological Products
- Valneva
- Bharat Biotech
- Cheng Da Biology
- Biocelect Pty Ltd
- Glovax Co., Ltd.
1. How big is the global Live Attenuated Japanese Encephalitis Vaccine market?
2. What is the demand of the global Live Attenuated Japanese Encephalitis Vaccine market?
3. What is the year over year growth of the global Live Attenuated Japanese Encephalitis Vaccine market?
4. What is the production and production value of the global Live Attenuated Japanese Encephalitis Vaccine market?
5. Who are the key producers in the global Live Attenuated Japanese Encephalitis Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Live Attenuated Japanese Encephalitis Vaccine Introduction
1.2 World Live Attenuated Japanese Encephalitis Vaccine Supply & Forecast
1.2.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.2.3 World Live Attenuated Japanese Encephalitis Vaccine Pricing Trends (2018-2029)
1.3 World Live Attenuated Japanese Encephalitis Vaccine Production by Region (Based on Production Site)
1.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018-2029)
1.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2018-2029)
1.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2029)
1.3.4 North America Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.5 Europe Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.6 China Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.7 Japan Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Japanese Encephalitis Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Live Attenuated Japanese Encephalitis Vaccine Demand (2018-2029)
2.2 World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region
2.2.1 World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region (2018-2023)
2.2.2 World Live Attenuated Japanese Encephalitis Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.4 China Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.5 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.6 Japan Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.7 South Korea Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.8 ASEAN Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.9 India Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
3 WORLD LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Live Attenuated Japanese Encephalitis Vaccine Production by Manufacturer (2018-2023)
3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023)
3.4 Live Attenuated Japanese Encephalitis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Japanese Encephalitis Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Japanese Encephalitis Vaccine in 2022
3.6 Live Attenuated Japanese Encephalitis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Japanese Encephalitis Vaccine Market: Region Footprint
3.6.2 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
4.5 China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share
4.5.1 China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
4.6 Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.5ml
5.2.2 1ml
5.2.3 2.5ml
5.3 Market Segment by Type
5.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2018-2029)
5.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2018-2029)
5.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2018-2029)
6.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2018-2029)
6.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Chengdu Institute of Biological Products
7.3.1 Chengdu Institute of Biological Products Details
7.3.2 Chengdu Institute of Biological Products Major Business
7.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.3.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Details
7.4.2 Wuhan Institute of Biological Products Major Business
7.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.4.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Details
7.5.2 Lanzhou Institute of Biological Products Major Business
7.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.5.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Beijing Temple of Heaven Biological Products
7.6.1 Beijing Temple of Heaven Biological Products Details
7.6.2 Beijing Temple of Heaven Biological Products Major Business
7.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Beijing Temple of Heaven Biological Products Recent Developments/Updates
7.6.6 Beijing Temple of Heaven Biological Products Competitive Strengths & Weaknesses
7.7 Valneva
7.7.1 Valneva Details
7.7.2 Valneva Major Business
7.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Valneva Recent Developments/Updates
7.7.6 Valneva Competitive Strengths & Weaknesses
7.8 Bharat Biotech
7.8.1 Bharat Biotech Details
7.8.2 Bharat Biotech Major Business
7.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Bharat Biotech Recent Developments/Updates
7.8.6 Bharat Biotech Competitive Strengths & Weaknesses
7.9 Cheng Da Biology
7.9.1 Cheng Da Biology Details
7.9.2 Cheng Da Biology Major Business
7.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Cheng Da Biology Recent Developments/Updates
7.9.6 Cheng Da Biology Competitive Strengths & Weaknesses
7.10 Biocelect Pty Ltd
7.10.1 Biocelect Pty Ltd Details
7.10.2 Biocelect Pty Ltd Major Business
7.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biocelect Pty Ltd Recent Developments/Updates
7.10.6 Biocelect Pty Ltd Competitive Strengths & Weaknesses
7.11 Glovax Co., Ltd.
7.11.1 Glovax Co., Ltd. Details
7.11.2 Glovax Co., Ltd. Major Business
7.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Glovax Co., Ltd. Recent Developments/Updates
7.11.6 Glovax Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Live Attenuated Japanese Encephalitis Vaccine Industry Chain
8.2 Live Attenuated Japanese Encephalitis Vaccine Upstream Analysis
8.2.1 Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Live Attenuated Japanese Encephalitis Vaccine Production Mode
8.6 Live Attenuated Japanese Encephalitis Vaccine Procurement Model
8.7 Live Attenuated Japanese Encephalitis Vaccine Industry Sales Model and Sales Channels
8.7.1 Live Attenuated Japanese Encephalitis Vaccine Sales Model
8.7.2 Live Attenuated Japanese Encephalitis Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Live Attenuated Japanese Encephalitis Vaccine Introduction
1.2 World Live Attenuated Japanese Encephalitis Vaccine Supply & Forecast
1.2.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.2.3 World Live Attenuated Japanese Encephalitis Vaccine Pricing Trends (2018-2029)
1.3 World Live Attenuated Japanese Encephalitis Vaccine Production by Region (Based on Production Site)
1.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018-2029)
1.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2018-2029)
1.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2029)
1.3.4 North America Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.5 Europe Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.6 China Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.3.7 Japan Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Japanese Encephalitis Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Live Attenuated Japanese Encephalitis Vaccine Demand (2018-2029)
2.2 World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region
2.2.1 World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region (2018-2023)
2.2.2 World Live Attenuated Japanese Encephalitis Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.4 China Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.5 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.6 Japan Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.7 South Korea Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.8 ASEAN Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
2.9 India Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029)
3 WORLD LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Live Attenuated Japanese Encephalitis Vaccine Production by Manufacturer (2018-2023)
3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023)
3.4 Live Attenuated Japanese Encephalitis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Japanese Encephalitis Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Japanese Encephalitis Vaccine in 2022
3.6 Live Attenuated Japanese Encephalitis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Japanese Encephalitis Vaccine Market: Region Footprint
3.6.2 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
4.5 China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share
4.5.1 China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
4.6 Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.5ml
5.2.2 1ml
5.2.3 2.5ml
5.3 Market Segment by Type
5.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2018-2029)
5.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2018-2029)
5.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2018-2029)
6.3.2 World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2018-2029)
6.3.3 World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Chengdu Institute of Biological Products
7.3.1 Chengdu Institute of Biological Products Details
7.3.2 Chengdu Institute of Biological Products Major Business
7.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.3.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Details
7.4.2 Wuhan Institute of Biological Products Major Business
7.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.4.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Details
7.5.2 Lanzhou Institute of Biological Products Major Business
7.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.5.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Beijing Temple of Heaven Biological Products
7.6.1 Beijing Temple of Heaven Biological Products Details
7.6.2 Beijing Temple of Heaven Biological Products Major Business
7.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Beijing Temple of Heaven Biological Products Recent Developments/Updates
7.6.6 Beijing Temple of Heaven Biological Products Competitive Strengths & Weaknesses
7.7 Valneva
7.7.1 Valneva Details
7.7.2 Valneva Major Business
7.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Valneva Recent Developments/Updates
7.7.6 Valneva Competitive Strengths & Weaknesses
7.8 Bharat Biotech
7.8.1 Bharat Biotech Details
7.8.2 Bharat Biotech Major Business
7.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Bharat Biotech Recent Developments/Updates
7.8.6 Bharat Biotech Competitive Strengths & Weaknesses
7.9 Cheng Da Biology
7.9.1 Cheng Da Biology Details
7.9.2 Cheng Da Biology Major Business
7.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Cheng Da Biology Recent Developments/Updates
7.9.6 Cheng Da Biology Competitive Strengths & Weaknesses
7.10 Biocelect Pty Ltd
7.10.1 Biocelect Pty Ltd Details
7.10.2 Biocelect Pty Ltd Major Business
7.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biocelect Pty Ltd Recent Developments/Updates
7.10.6 Biocelect Pty Ltd Competitive Strengths & Weaknesses
7.11 Glovax Co., Ltd.
7.11.1 Glovax Co., Ltd. Details
7.11.2 Glovax Co., Ltd. Major Business
7.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
7.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Glovax Co., Ltd. Recent Developments/Updates
7.11.6 Glovax Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Live Attenuated Japanese Encephalitis Vaccine Industry Chain
8.2 Live Attenuated Japanese Encephalitis Vaccine Upstream Analysis
8.2.1 Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Live Attenuated Japanese Encephalitis Vaccine Production Mode
8.6 Live Attenuated Japanese Encephalitis Vaccine Procurement Model
8.7 Live Attenuated Japanese Encephalitis Vaccine Industry Sales Model and Sales Channels
8.7.1 Live Attenuated Japanese Encephalitis Vaccine Sales Model
8.7.2 Live Attenuated Japanese Encephalitis Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2018-2023)
Table 9. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2024-2029)
Table 10. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Live Attenuated Japanese Encephalitis Vaccine Major Market Trends
Table 13. World Live Attenuated Japanese Encephalitis Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Live Attenuated Japanese Encephalitis Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Japanese Encephalitis Vaccine Producers in 2022
Table 18. World Live Attenuated Japanese Encephalitis Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Live Attenuated Japanese Encephalitis Vaccine Producers in 2022
Table 20. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Live Attenuated Japanese Encephalitis Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Japanese Encephalitis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Japanese Encephalitis Vaccine Competitive Factors
Table 27. Live Attenuated Japanese Encephalitis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Live Attenuated Japanese Encephalitis Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 37. China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 47. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 64. Novartis Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 70. Sanofi Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Institute of Biological Products Major Business
Table 75. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 76. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Chengdu Institute of Biological Products Recent Developments/Updates
Table 78. Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
Table 79. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 80. Wuhan Institute of Biological Products Major Business
Table 81. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 82. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Wuhan Institute of Biological Products Recent Developments/Updates
Table 84. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 85. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Lanzhou Institute of Biological Products Major Business
Table 87. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 88. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 90. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Beijing Temple of Heaven Biological Products Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Temple of Heaven Biological Products Major Business
Table 93. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 94. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Beijing Temple of Heaven Biological Products Recent Developments/Updates
Table 96. Beijing Temple of Heaven Biological Products Competitive Strengths & Weaknesses
Table 97. Valneva Basic Information, Manufacturing Base and Competitors
Table 98. Valneva Major Business
Table 99. Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 100. Valneva Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Valneva Recent Developments/Updates
Table 102. Valneva Competitive Strengths & Weaknesses
Table 103. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Bharat Biotech Major Business
Table 105. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 106. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Bharat Biotech Recent Developments/Updates
Table 108. Bharat Biotech Competitive Strengths & Weaknesses
Table 109. Cheng Da Biology Basic Information, Manufacturing Base and Competitors
Table 110. Cheng Da Biology Major Business
Table 111. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 112. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Cheng Da Biology Recent Developments/Updates
Table 114. Cheng Da Biology Competitive Strengths & Weaknesses
Table 115. Biocelect Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Biocelect Pty Ltd Major Business
Table 117. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 118. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biocelect Pty Ltd Recent Developments/Updates
Table 120. Glovax Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 121. Glovax Co., Ltd. Major Business
Table 122. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 123. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine Upstream (Raw Materials)
Table 125. Live Attenuated Japanese Encephalitis Vaccine Typical Customers
Table 126. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
Table 1. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Live Attenuated Japanese Encephalitis Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2018-2023)
Table 9. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2024-2029)
Table 10. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Live Attenuated Japanese Encephalitis Vaccine Major Market Trends
Table 13. World Live Attenuated Japanese Encephalitis Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Live Attenuated Japanese Encephalitis Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Live Attenuated Japanese Encephalitis Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Japanese Encephalitis Vaccine Producers in 2022
Table 18. World Live Attenuated Japanese Encephalitis Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Live Attenuated Japanese Encephalitis Vaccine Producers in 2022
Table 20. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Live Attenuated Japanese Encephalitis Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Japanese Encephalitis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Japanese Encephalitis Vaccine Competitive Factors
Table 27. Live Attenuated Japanese Encephalitis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Japanese Encephalitis Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Live Attenuated Japanese Encephalitis Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Live Attenuated Japanese Encephalitis Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 37. China Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share (2018-2023)
Table 47. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Live Attenuated Japanese Encephalitis Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Live Attenuated Japanese Encephalitis Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 64. Novartis Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 70. Sanofi Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Institute of Biological Products Major Business
Table 75. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 76. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Chengdu Institute of Biological Products Recent Developments/Updates
Table 78. Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
Table 79. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 80. Wuhan Institute of Biological Products Major Business
Table 81. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 82. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Wuhan Institute of Biological Products Recent Developments/Updates
Table 84. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 85. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Lanzhou Institute of Biological Products Major Business
Table 87. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 88. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 90. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Beijing Temple of Heaven Biological Products Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Temple of Heaven Biological Products Major Business
Table 93. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 94. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Beijing Temple of Heaven Biological Products Recent Developments/Updates
Table 96. Beijing Temple of Heaven Biological Products Competitive Strengths & Weaknesses
Table 97. Valneva Basic Information, Manufacturing Base and Competitors
Table 98. Valneva Major Business
Table 99. Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 100. Valneva Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Valneva Recent Developments/Updates
Table 102. Valneva Competitive Strengths & Weaknesses
Table 103. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Bharat Biotech Major Business
Table 105. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 106. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Bharat Biotech Recent Developments/Updates
Table 108. Bharat Biotech Competitive Strengths & Weaknesses
Table 109. Cheng Da Biology Basic Information, Manufacturing Base and Competitors
Table 110. Cheng Da Biology Major Business
Table 111. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 112. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Cheng Da Biology Recent Developments/Updates
Table 114. Cheng Da Biology Competitive Strengths & Weaknesses
Table 115. Biocelect Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Biocelect Pty Ltd Major Business
Table 117. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 118. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biocelect Pty Ltd Recent Developments/Updates
Table 120. Glovax Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 121. Glovax Co., Ltd. Major Business
Table 122. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 123. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine Upstream (Raw Materials)
Table 125. Live Attenuated Japanese Encephalitis Vaccine Typical Customers
Table 126. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture
Figure 2. World Live Attenuated Japanese Encephalitis Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Live Attenuated Japanese Encephalitis Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 5. World Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 10. China Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 12. Live Attenuated Japanese Encephalitis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Japanese Encephalitis Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Japanese Encephalitis Vaccine Markets in 2022
Figure 26. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 32. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Type in 2022
Figure 34. 0.5ml
Figure 35. 1ml
Figure 36. 2.5ml
Figure 37. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Live Attenuated Japanese Encephalitis Vaccine Industry Chain
Figure 48. Live Attenuated Japanese Encephalitis Vaccine Procurement Model
Figure 49. Live Attenuated Japanese Encephalitis Vaccine Sales Model
Figure 50. Live Attenuated Japanese Encephalitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture
Figure 2. World Live Attenuated Japanese Encephalitis Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Live Attenuated Japanese Encephalitis Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 5. World Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 10. China Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Live Attenuated Japanese Encephalitis Vaccine Production (2018-2029) & (K Units)
Figure 12. Live Attenuated Japanese Encephalitis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Live Attenuated Japanese Encephalitis Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Japanese Encephalitis Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Japanese Encephalitis Vaccine Markets in 2022
Figure 26. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Live Attenuated Japanese Encephalitis Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Live Attenuated Japanese Encephalitis Vaccine Production Market Share 2022
Figure 32. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Type in 2022
Figure 34. 0.5ml
Figure 35. 1ml
Figure 36. 2.5ml
Figure 37. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Live Attenuated Japanese Encephalitis Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. World Live Attenuated Japanese Encephalitis Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Live Attenuated Japanese Encephalitis Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Live Attenuated Japanese Encephalitis Vaccine Industry Chain
Figure 48. Live Attenuated Japanese Encephalitis Vaccine Procurement Model
Figure 49. Live Attenuated Japanese Encephalitis Vaccine Sales Model
Figure 50. Live Attenuated Japanese Encephalitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
